Effects of dexamethasone on iliac fascia block in different ways

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200058065

Enrollment

Unknown

Registered

2022-03-28

Start date

2022-04-01

Completion date

Unknown

Last updated

2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group 1:Intravenous dexamethasone 5mg combined with iliac fascia block (0.375% ropivacaine 30ml)

Group 2:Iliac fascia block was performed (0.375% ropivacaine 30ml+ dexamethasone 5mg)

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-80 years who underwent hip surgery in our hospital; 2. American Society of Anesthesiologists (ASA) Grade ?-?; 3. Have a certain understanding ability and cooperate with the anesthesia process; 4. Be informed of this study, participate voluntarily and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Surgery on both hips; 2. The patient is expected to be unable to tolerate general anesthesia; 3. Regular use of opioids or corticosteroids; 4. Dexamethasone contraindication; 5. Patients with diabetic peripheral neuropathy; 6. History of allergies to any medications in the study.

Design outcomes

Primary

Measure	Time frame
First postoperative analgesia request time;	—

Secondary

Measure	Time frame
Total consumption of analgesics;Incidence of postoperative nausea and vomiting;Changes in blood glucose in patients;Numerical Rating Scale for Pain (NRS);Duration of motor block;	—

Countries

China

Contacts

Public ContactZheng Jun

782459453@qq.com+86 18131375009

Outcome results